Glass Jacobson Investment Advisors’s Medifast MED Stock Holding History

Glass Jacobson Investment Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75	Hold	7	–	–	﹤0.01%	616
2026 Q1	$72	Hold	7	–	–	﹤0.01%	606
2025 Q4	$75	Hold	7	–	–	﹤0.01%	581
2025 Q3	$96	Hold	7	–	–	﹤0.01%	579
2025 Q2	$99	Hold	7	–	–	﹤0.01%	557
2025 Q1	$124	Hold	7	–	–	﹤0.01%	831
2024 Q4	$124	Hold	7	–	–	﹤0.01%	831
2024 Q3	$134	Hold	7	–	–	﹤0.01%	751
2024 Q2	$153	Hold	7	–	–	﹤0.01%	744
2024 Q1	$269	Hold	7	–	–	﹤0.01%	730
2023 Q4	$471	Hold	7	–	–	﹤0.01%	685
2023 Q3	$524	Hold	7	–	–	﹤0.01%	748
2023 Q2	$646	Buy	+7	New	+$623	﹤0.01%	736

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

Commons Capital Needham, Massachusetts $143M AUM 30.09% 1-Year Est. Return

VFO

Virtus Family Office El Paso, Texas $126M AUM 23.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GLA

Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return

SIM

SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Glass Jacobson Investment Advisors's MED Position: Q2 2026 in Review

Glass Jacobson Investment Advisors held its Medifast (MED) position steady in Q2 2026 at 7 shares worth $75. The position accounts for ﹤0.01% of the portfolio, ranked #616.

Glass Jacobson Investment Advisors first reported a position in MED in Q2 2023 and has held it in 13 quarters since. The position peaked at $646 in Q2 2023. 49 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Glass Jacobson Investment Advisors held 7 shares of Medifast worth $75 as of Q2 2026.
Glass Jacobson Investment Advisors left its Medifast share count unchanged in Q2 2026.
Medifast made up ﹤0.01% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #616 holding.
Glass Jacobson Investment Advisors first reported a position in Medifast in Q2 2023 and has held it in 13 quarters since.
Glass Jacobson Investment Advisors's Medifast position peaked at $646 in Q2 2023.
49 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.